COMORBIDITY NEUROLOGY
- Astrakhan State Medical University, Astrakhan, Russia
ABSTRACT
Clinical neurodermatology is a modern scientific field that arose at the junction of two disciplines. It is an underrated but important specialty that focuses on the interaction of dermatology and neurology. Its relevance is determined by a significant number of skin diseases accompanied by neurological disorders, which often develop in the same patient at the same time. Despite the high prevalence of neurodermatological problems in daily practice, most doctors are not fully aware of them. Among dermatologists and neurologists, there is a lack of understanding and confidence in the need to discuss the diagnosis and treatment of skin neurological pathology. Therefore, knowledge of biopsychosocial approaches and an approach to interaction involving neurologists, psychiatrists, dermatologists and psychologists in this field is important.
KEYWORDS: clinical neurodermatology, skin, nervous tissue
For citation: Sadretdinov R.A., Mamina R.M. Clinical Neurodermatology: a Look at the Problem. A Review. Comorbidity Neurology. 2024; 1 (3): 95-100. https://doi.org/10.62505/3034-185x-2024-1-3-95-100
*For correspondence: Renat A. Sadretdinov, Dr. Sci. (Med.), Associate Professor of the Department of Clinical Immunology, Astrakhan State Medical University, Astrakhan, Russia, e-mail: likhoradka@mail.ru.
REFERENCES
1.Kimball A.B., Jacobson C., Weiss S., Vreeland M.G., Ying Wu. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-92. https://doi.org/10.2165/00128071-200506060-00005
2.Koblenzer C.S. Psychosomatic dermatologist-psychoanalyst’s viewpoint. Arch Dermatol. 1983; 119: 501-12
3.O’Sullivan R.L., Lipper G., Lerner E.A. The neuro-immuno-cutaneous-endocrine network: Relationship of mind and skin. Arch Dermatol 1998; 134: 1431-1435. https://doi.org/10.1001/archderm.134.11.1431
4.Arck P.C., Slominski A., Theoharides T.C., Peters E.M., Paus R. Neuroimmunology of stress: Skin takes center stage. J Invest Dermatol. 2006; 126: 1697-1704. https://doi.org/10.1038/sj.jid.5700104
5.Schmidt-Ott G., Jacobs R., Jager B., et al. Stress induced-endocrine and immunological changes in psoriasis patients and healthy controls: a preliminary study. Psychother Psychosom. 1998; 67: 37-42. https://doi.org/10.1159/000012257
6.Misery L. Neuro-immuno-cutaneous system (NICS). Pathol Biol (Paris). 1996; 44: 867-874
7.Koo J.Y.M., Lee C.S. General approach to evaluating psychodermatological disorders. Psychocutaneous Medicine. New York, NY: Marcel Dekker, Inc; 2003:1-29
8.Jafferany M., Vander Stoep A., Dumitrescu A., Hornung R.L. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: Results of a survey study. Int J Dermatol 2010; 49: 784-9. https://doi.org/10.1111/j.1365-4632.2009.04372.x
9.Amit Garg M., Chren M., Sanas L., et al. Psychological stress perturbs epidermal barrier homeostasis. Arch Dermatol. 2001; 137: 53-59
10.Humphreys F., Humphreys M.S. Psychiatric morbidity and skin disease: What dermatologists think they see. Br J Dermatol. 1998; 139: 679-81
11.Picardi A., Adler D.A., Abeni D., Chang H., Pasquini P., Rogers W.H., et al. Screening for depressive disorders in patients with skin diseases: A comparison of three screeners. Acta Derm Venereol. 2005; 85: 414-419. https://doi.org/10.1080/00015550510034966
12.Picardi A.I., Aberi D., Melchi C.F., et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000; 143: 983-991. https://doi.org/10.1046/j.1365-2133.2000.03831.x
13.Nemiah J.C., Sifneos P.E. Psychosomatic illness: A problem in communication. Psychother Psychosom. 1970; 18: 154-60
14.Taylor G.J., Bagby R.M. New trends in alexithymia research. Psychother Psychosom. 2004; 73: 68-77. https://doi.org/10.1159/000075537
15.Richards H.L., Fortune D.G, Griffiths C.E., Main C.J. Alexithymia in patients with psoriasis. Clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20.J Psychosom Res. 2005; 58: 98-96. https://doi.org/10.1016/j.jpsychores.2004.03.009
16.Griffiths C.E., Richards H.L. Psychological influence in psoriasis. Clin Exp Dermatol 2001; 26: 338-342. https://doi.org/10.1046/j.1365-2230.2001.00834.x
17.Harvima R.J., Viinamak H., Harvima I.T., et al. Association of psychic stress with clinical severity and symptoms of psoriatric patients. Acta Derm Venereol 1996; 76: 467-471. https://doi.org/10.2340/0001555576467471
18.Gupta M.A., Gupta A.K. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36: 259-262. https://doi.org/10.1046/j.1365-4362.1997.00032.x
19.Ginsburg I.H., Link B.G. Feelings of stigmatization in patients with psoriasis J Am Acad Dermatol 1989; 20: 53-63. https://doi.org/10.1016/s0190-9622(89)70007-4
20.Gupta M.A., Gupta A.K., Ellis C.N., et al. Some psychosomatic aspects of psoriasis. Adv Dermatol. 1990; 5: 21-30
21.Gil K.M., Keefe F.J., Sampson H.A., et al. The relation of stress and family environment to atopic dermatitis symptoms in children. J Psychosom Res 1987; 31: 673-684. https://doi.org/10.1016/0022-3999(87)90016-x
22.Schut C., Bosbach S., Gieler U., Kupfer J. Personality traits, depression and itch in patients with atopic dermatitis in an experimental setting: A regression analysis. Acta Derm Venereol 2014; 94: 20-25. https://doi.org/10.2340/00015555-1634
23.Sainz B., Loutsch J.M., Marquart M.E., et al. Stress associated immunomodulation and herpes simplex virus infection. Med Hypotheses. 2001; 56: 348-356. https://doi.org/10.1054/mehy.2000.1219
24.Koblenzer C.S. Psychological and psychiatric aspects of itching. In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York; NY: McGraw-Hill; 1994: 347-356
25.Garcia-Hernandez M.J., Ruiz-Doblado S., Rodriguez-Pichardo A., et al. Alopecia areata, stress and psychiatric disorders; a review. J Dermatol. 1999; 26: 625-632. https://doi.org/10.1111/j.1346-8138.1999.tb02063.x
26.Papadopoulos L., Bor R., Legg C., et al. Impact of life events on the onset of vitiligo in adults: preliminaryevidence for a psychological dimension in etiology. Clin Exp Dermatol. 1998; 23: 243-248. https://doi.org/10.1046/j.1365-2230.1998.00384.x
27. Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998; 139: 846-850. https://doi.org/10.1046/j.1365-2133.1998.02511.x
28.Saitta P., Keehan P., Yousif J., Way B.V., Grekin S., Brancaccio R. An update on the presence of psychiatric comorbidities in acne patients, part 2: Depression, anxiety, and suicide. Cutis 2011; 88: 92-97
29.Mattoo S.K., Handa S., Kaur I., Gupta N., Malhotra R. Psychiatric morbidity in vitiligo and psoriasis: A comparative study from India. J Dermatol 2001; 28: 424-432. https://doi.org/10.1111/j.1346-8138.2001.tb00004.x
30.Colon E.A, Popkin M.K., Callies A.L., et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991; 32: 245-251. https://doi.org/10.1016/0010-440x(91)90045-e
31.Koo J., Gambla C. Cutaneous sensory disorder. Dermatol Clin 1996; 14: 497-502. https://doi.org/10.1016/s0733-8635(05)70377-6
32.Jafferany M. Psychodermatology: A Guide to Understanding Common Psychocutaneous Disorders. Prim Care Companion J Clin Psychiatry. 2007; 9 (3): 203-213. https://doi.org/10.4088/pcc.v09n0306
33.Archer-Dubon C., Orozco-Topete R., Reyes-Gutierrez E. Two cases of psychogenic purpura. Rev Invest Clin 1998; 50: 145-148
34.Cotterill J.A., Cunlife W.J. Suicide in dermatological patients. Br J Dermatol. 1997; 137: 246-250. https://doi.org/10.1046/j.1365-2133.1997.18131897.x
35.Yadav S., Narang T., Kumaran M.S. Psychodermatology: A comprehensive review. Indian J Dermatol Venereol Leprol. 2013; 79 (2): 176-192. https://doi.org/10.4103/0378-6323.107632
36.Fried R.G. Nonpharmacologic treatment in psychodermatology. Dermatol Clin 2002; 20: 177-185. https://doi.org/10.1016/s0733-8635(03)00055-x
37.Shenefelt P.D. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003; 16: 114-122. https://doi.org/10.1046/j.1529-8019.2003.01620.x
38.Shenefelt P.D. Hypnosis in dermatology. Arch Dermatol. 2000; 136: 393-398. https://doi.org/10.1001/archderm.136.3.393
39.Jafferany M., Vander Stoep A., Dumitrescu A., Hornung R.L. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: Results of a survey study. Int J Dermatol 2010; 49: 784-9. https://doi.org/10.1111/j.1365-4632.2009.04372.x
ADDITIONAL INFORMATION
Renat A. Sadretdinov, Dr. Sci. (Med.), Associate Professor of the Department of Clinical Immunology, Astrakhan State Medical University, Astrakhan, Russia. E-mail: likhoradka@mail.ru. ORCID: https://orcid.org/0000-0003-0620-2204
Regina M. Mamina, Cand. Sci. (Med.), Assistant of the Department of Neurology and Neurosurgery, Astrakhan State Medical University, Astrakhan, Russia. E-mail: regaisha@yandex.ru. ORCID: https://orcid.org/0000-0002-8998-8881
Author contributions. All authors confirm the compliance of their authorship, according to international ICMJE criteria (all authors made a significant contribution to the development of the concept, research and preparation of the article, read and approved the final version before publication). Sadretdinov R.A., Mamina R.M. – searched for suitable literature; correcting the text in accordance with the basic requirements.
Funding. This study was supported by any external sources of funding.
Disclosure. The authors declare that they have no competing interests.
The content is available under the Creative Commons Attribution 4.0 License.
©2024. Renat A. Sadretdinov, Regina M. Mamina